Daniel P. Silver, MD, PhD

Publications

Tung N, Miron A, Schnitt SJ, Gautam S, Fetten K, Kaplan J, Yassin Y, Buraimoh A, Kim JY, Szasz AM, Tian R, Wang ZC, Collins LC, Brock J, Krag K, Legare RD, Sgroi D, Ryan PD, Silver D, Garber JE, Richardson AL.Prevalence and predictors of loss of wild type
21080930
Liu JF, Silver DP.Poly ADP-ribose polymerase inhibitors: science and current clinical development.Curr Opin Oncol. 2010 Nov;22(6):567-72.
20739886
Anders CK, Winer EP, Ford JM, Dent R, Silver DP, Sledge GW, Carey LA.Poly(ADP-Ribose) polymerase inhibition: "Targeted" therapy for triple-negative breast cancer.Clin Cancer Res. 2010 Oct 1;16(19):4702-10.
20858840
Silver DP, Richardson AL, Eklund AC, Wang ZC, Szallasi Z, Li Q, Juul N, Leong CO, Calogrias D, Buraimoh A, Fatima A, Gelman RS, Ryan PD, Tung NM, De Nicolo A, Ganesan S, Miron A, Colin C, Sgroi DC, Ellisen LW, Winer EP, Garber JE.Efficacy of Neoadjuvant C
Silver DP, Richardson AL, Eklund AC, Wang ZC, Szallasi Z, Li Q, Juul N, Leong CO, Calogrias D, Buraimoh A, Fatima A, Gelman RS, Ryan PD, Tung NM, De Nicolo A, Ganesan S, Miron A, Colin C, Sgroi DC, Ellisen LW, Winer EP, Garber JE.Efficacy of neoadjuvant C
20100965
Stephens PJ, McBride DJ, Lin ML, Varela I, Pleasance ED, Simpson JT, Stebbings LA, Leroy C, Edkins S, Mudie LJ, Greenman CD, Jia M, Latimer C, Teague JW, Lau KW, Burton J, Quail MA, Swerdlow H, Churcher C, Natrajan R, Sieuwerts AM, Martens JW, Silver DP,
20033038
Zhao JJ, Silver DP.Estrogen Receptor-Negative Breast Cancer: New Insights into Subclassification and Targeting.Clin Cancer Res. 2009 Oct 15;15(20):6309-10.
19825953
Kalaszczynska I, Geng Y, Iino T, Mizuno S, Choi Y, Kondratiuk I, Silver DP, Wolgemuth DJ, Akashi K, Sicinski P.Cyclin A is redundant in fibroblasts but essential in hematopoietic and embryonic stem cells.Cell. 2009 Jul 23;138(2):352-65.
19592082
Iglehart JD, Silver DP.Synthetic lethality--a new direction in cancer-drug development.N Engl J Med. 2009 Jul 9;361(2):189-91.
19553640
Iglehart JD, and Silver DP.A New Direction in Cancer-Drug Development.NEJM..
Matera I, Watkins-Chow DE, Loftus SK, Hou L, Incao A, Silver DL, Rivas C, Elliott EC, Baxter LL, Pavan WJ.A sensitized mutagenesis screen identifies Gli3 as a modifier of Sox10 neurocristopathy.Hum Mol Genet. 2008 Jul 15;17(14):2118-31.
18397875
Silver DL, Hou L, Somerville R, Young ME, Apte SS, Pavan WJ.The secreted metalloprotease ADAMTS20 is required for melanoblast survival.PLoS Genet. 2008 Feb;4(2):e1000003.
18454205
Livingston DM, Silver DP.Cancer: crossing over to drug resistance.Nature. 2008 Feb 28;451(7182):1066-7.
18305536
Zhu W, Saddar S, Seetharam D, Chambliss KL, Longoria C, Silver DL, Yuhanna IS, Shaul PW, Mineo C.The scavenger receptor class B type I adaptor protein PDZK1 maintains endothelial monolayer integrity.Circ Res. 2008 Feb 29;102(4):480-7.
18174467
Gopal M, Silver D.Fibromatosis of the appendix and cecum.J Minim Invasive Gynecol. 2007 Nov-Dec;14(6):678.
17980324
Silver DP, Dimitrov SD, Feunteun J, Gelman R, Drapkin R, Lu SD, Shestakova E, Velmurugan S, Denunzio N, Dragomir S, Mar J, Liu X, Rottenberg S, Jonkers J, Ganesan S, Livingston DM.Further evidence for BRCA1 communication with the inactive X chromosome.Cel
17350581
Ganesan S, Richardson AL, Wang ZC, Iglehart JD, Miron A, Feunteun J, Silver D, Livingston DM.Abnormalities of the Inactive X Chromosome Are a Common Feature of BRCA1 Mutant and Sporadic Basal-like Breast Cancer.Cold Spring Harb Symp Quant Biol. 2005;70:93
16869742
Tuveson DA, Shaw AT, Willis NA, Silver DP, Jackson EL, Chang S, Mercer KL, Grochow R, Hock H, Crowley D, Hingorani SR, Zaks T, King C, Jacobetz MA, Wang L, Bronson RT, Orkin SH, DePinho RA, Jacks T.Endogenous oncogenic K-ras(G12D) stimulates proliferation
15093544
Ganesan S, Silver DP, Drapkin R, Greenberg R, Feunteun J, Livingston DM.Association of BRCA1 with the inactive X chromosome and XIST RNA.Philos Trans R Soc Lond B Biol Sci. 2004 Jan 29;359(1441):123-8.
15065664
Silver DP.HIN-1 and the nosology of breast cancer.Cancer Biol Ther. 2003 Sep-Oct;2(5):564-5.
14614328
Ganesan S, Silver DP, Greenberg RA, Avni D, Drapkin R, Miron A, Mok SC, Randrianarison V, Brodie S, Salstrom J, Rasmussen TP, Klimke A, Marrese C, Marahrens Y, Deng CX, Feunteun J, Livingston DM.BRCA1 supports XIST RNA concentration on the inactive X chro
12419249
Silver DP, Livingston DM.Self-excising retroviral vectors encoding the Cre recombinase overcome Cre-mediated cellular toxicity.Mol Cell. 2001 Jul;8(1):233-43.
11511376
Chen J, Silver DP, Walpita D, Cantor SB, Gazdar AF, Tomlinson G, Couch FJ, Weber BL, Ashley T, Livingston DM, Scully R.Stable interaction between the products of the BRCA1 and BRCA2 tumor suppressor genes in mitotic and meiotic cells.Mol Cell. 1998 Sep;2(
9774970

Advanced search
DF/HCC Directory Login Update Member Profile Change Account Settings Applying for Membership Benefits Requirements Responsibilities	Daniel P. Silver, MD, PhD Publications Tung N, Miron A, Schnitt SJ, Gautam S, Fetten K, Kaplan J, Yassin Y, Buraimoh A, Kim JY, Szasz AM, Tian R, Wang ZC, Collins LC, Brock J, Krag K, Legare RD, Sgroi D, Ryan PD, Silver D, Garber JE, Richardson AL.Prevalence and predictors of loss of wild type 21080930 Liu JF, Silver DP.Poly ADP-ribose polymerase inhibitors: science and current clinical development.Curr Opin Oncol. 2010 Nov;22(6):567-72. 20739886 Anders CK, Winer EP, Ford JM, Dent R, Silver DP, Sledge GW, Carey LA.Poly(ADP-Ribose) polymerase inhibition: "Targeted" therapy for triple-negative breast cancer.Clin Cancer Res. 2010 Oct 1;16(19):4702-10. 20858840 Silver DP, Richardson AL, Eklund AC, Wang ZC, Szallasi Z, Li Q, Juul N, Leong CO, Calogrias D, Buraimoh A, Fatima A, Gelman RS, Ryan PD, Tung NM, De Nicolo A, Ganesan S, Miron A, Colin C, Sgroi DC, Ellisen LW, Winer EP, Garber JE.Efficacy of Neoadjuvant C Silver DP, Richardson AL, Eklund AC, Wang ZC, Szallasi Z, Li Q, Juul N, Leong CO, Calogrias D, Buraimoh A, Fatima A, Gelman RS, Ryan PD, Tung NM, De Nicolo A, Ganesan S, Miron A, Colin C, Sgroi DC, Ellisen LW, Winer EP, Garber JE.Efficacy of neoadjuvant C 20100965 Stephens PJ, McBride DJ, Lin ML, Varela I, Pleasance ED, Simpson JT, Stebbings LA, Leroy C, Edkins S, Mudie LJ, Greenman CD, Jia M, Latimer C, Teague JW, Lau KW, Burton J, Quail MA, Swerdlow H, Churcher C, Natrajan R, Sieuwerts AM, Martens JW, Silver DP, 20033038 Zhao JJ, Silver DP.Estrogen Receptor-Negative Breast Cancer: New Insights into Subclassification and Targeting.Clin Cancer Res. 2009 Oct 15;15(20):6309-10. 19825953 Kalaszczynska I, Geng Y, Iino T, Mizuno S, Choi Y, Kondratiuk I, Silver DP, Wolgemuth DJ, Akashi K, Sicinski P.Cyclin A is redundant in fibroblasts but essential in hematopoietic and embryonic stem cells.Cell. 2009 Jul 23;138(2):352-65. 19592082 Iglehart JD, Silver DP.Synthetic lethality--a new direction in cancer-drug development.N Engl J Med. 2009 Jul 9;361(2):189-91. 19553640 Iglehart JD, and Silver DP.A New Direction in Cancer-Drug Development.NEJM.. Matera I, Watkins-Chow DE, Loftus SK, Hou L, Incao A, Silver DL, Rivas C, Elliott EC, Baxter LL, Pavan WJ.A sensitized mutagenesis screen identifies Gli3 as a modifier of Sox10 neurocristopathy.Hum Mol Genet. 2008 Jul 15;17(14):2118-31. 18397875 Silver DL, Hou L, Somerville R, Young ME, Apte SS, Pavan WJ.The secreted metalloprotease ADAMTS20 is required for melanoblast survival.PLoS Genet. 2008 Feb;4(2):e1000003. 18454205 Livingston DM, Silver DP.Cancer: crossing over to drug resistance.Nature. 2008 Feb 28;451(7182):1066-7. 18305536 Zhu W, Saddar S, Seetharam D, Chambliss KL, Longoria C, Silver DL, Yuhanna IS, Shaul PW, Mineo C.The scavenger receptor class B type I adaptor protein PDZK1 maintains endothelial monolayer integrity.Circ Res. 2008 Feb 29;102(4):480-7. 18174467 Gopal M, Silver D.Fibromatosis of the appendix and cecum.J Minim Invasive Gynecol. 2007 Nov-Dec;14(6):678. 17980324 Silver DP, Dimitrov SD, Feunteun J, Gelman R, Drapkin R, Lu SD, Shestakova E, Velmurugan S, Denunzio N, Dragomir S, Mar J, Liu X, Rottenberg S, Jonkers J, Ganesan S, Livingston DM.Further evidence for BRCA1 communication with the inactive X chromosome.Cel 17350581 Ganesan S, Richardson AL, Wang ZC, Iglehart JD, Miron A, Feunteun J, Silver D, Livingston DM.Abnormalities of the Inactive X Chromosome Are a Common Feature of BRCA1 Mutant and Sporadic Basal-like Breast Cancer.Cold Spring Harb Symp Quant Biol. 2005;70:93 16869742 Tuveson DA, Shaw AT, Willis NA, Silver DP, Jackson EL, Chang S, Mercer KL, Grochow R, Hock H, Crowley D, Hingorani SR, Zaks T, King C, Jacobetz MA, Wang L, Bronson RT, Orkin SH, DePinho RA, Jacks T.Endogenous oncogenic K-ras(G12D) stimulates proliferation 15093544 Ganesan S, Silver DP, Drapkin R, Greenberg R, Feunteun J, Livingston DM.Association of BRCA1 with the inactive X chromosome and XIST RNA.Philos Trans R Soc Lond B Biol Sci. 2004 Jan 29;359(1441):123-8. 15065664 Silver DP.HIN-1 and the nosology of breast cancer.Cancer Biol Ther. 2003 Sep-Oct;2(5):564-5. 14614328 Ganesan S, Silver DP, Greenberg RA, Avni D, Drapkin R, Miron A, Mok SC, Randrianarison V, Brodie S, Salstrom J, Rasmussen TP, Klimke A, Marrese C, Marahrens Y, Deng CX, Feunteun J, Livingston DM.BRCA1 supports XIST RNA concentration on the inactive X chro 12419249 Silver DP, Livingston DM.Self-excising retroviral vectors encoding the Cre recombinase overcome Cre-mediated cellular toxicity.Mol Cell. 2001 Jul;8(1):233-43. 11511376 Chen J, Silver DP, Walpita D, Cantor SB, Gazdar AF, Tomlinson G, Couch FJ, Weber BL, Ashley T, Livingston DM, Scully R.Stable interaction between the products of the BRCA1 and BRCA2 tumor suppressor genes in mitotic and meiotic cells.Mol Cell. 1998 Sep;2( 9774970
Site Map Site Feedback Web Privacy Policy